Home › NCT03017118

Turmeric for Patients With Basal Joint Arthritis

A Randomized Controlled Trial Using Turmeric for Patients With Basal Joint Arthritis

Who can join

Ages 40 and older · All sexes

Inclusion Criteria:

* 40 years of age or older
* English fluency and literacy
* Seeking care for basal joint pain
* Tender over basal joint
* Positive distraction rotation test (rotation of the thumb metacarpal base while applying axial traction)
* Radiographic evidence of Eaton stage 1 and 2 only

Exclusion Criteria:

* Secondary gains (litigations or worker compensation) procedures that may interfere with patients' motivation for treatment
* Inability or unwillingness to participate in a trial study
* Rheumatoid Arthritis or other inflammatory disorder diagnoses
* Post-traumatic osteoarthritis
* Patients on Coumadin/Steroids/NSAIDs/Tylenol
* Diabetes Mellitus
* Pregnant or lactating women
* Basal joint arthritis of Eaton stage 3
* Patients seeking other treatment for their basal joint arthritis (splint, corticosteroid injection, surgery)

About the study

The aim of this study is to assess whether the use of a commercially available nutraceutical, turmeric, is an effective option to manage pain and stiffness in patients with basal joint arthritis. To conduct a pilot Randomized Controlled Trial evaluating the impact of turmeric on basal joint arthritis.

What is being tested

• Turmeric (dietary supplement)
• Placebo (other)

Sponsor: Massachusetts General Hospital · Participants: 60 · Started: Aug 9, 2017

Contact the study team

• Neal Chen, M.D. · Phone: 617-726-4700

Official record on ClinicalTrials.gov — NCT03017118

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.